Global Albumin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Albumin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
Albumin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Albumin market is projected to reach US$ 8186.2 million in 2034, increasing from US$ 5206 million in 2022, with the CAGR of 6.6% during the period of 2024 to 2034. Demand from Therapeutics and Vaccine Ingredient are the major drivers for the industry.
Global albumin control main manufactuers include CSL, Grifols, Shire (Baxalta), Octapharma, etc., totally accounting for about 42% of the market. Asia Pacific is the largest market, with a share over 65%. As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 93%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 72%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
CSL
Grifols
Shire (Baxalta)
Octapharma
Hualan Bio
CBPO
RAAS
Kedrion
Merck
LFB Group
Albumedix
Thermo Fisher Scientific
Segment by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Albumin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Albumin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Albumin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Albumin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Albumin introduction, etc. Albumin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Albumin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Albumin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Albumin market is projected to reach US$ 8186.2 million in 2034, increasing from US$ 5206 million in 2022, with the CAGR of 6.6% during the period of 2024 to 2034. Demand from Therapeutics and Vaccine Ingredient are the major drivers for the industry.
Global albumin control main manufactuers include CSL, Grifols, Shire (Baxalta), Octapharma, etc., totally accounting for about 42% of the market. Asia Pacific is the largest market, with a share over 65%. As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 93%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 72%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Albumin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
CSL
Grifols
Shire (Baxalta)
Octapharma
Hualan Bio
CBPO
RAAS
Kedrion
Merck
LFB Group
Albumedix
Thermo Fisher Scientific
Segment by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Segment by Application
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Albumin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Albumin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Albumin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Albumin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Albumin introduction, etc. Albumin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Albumin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices